Skip to content
Screener

Common Stock at other companies

Tenet Healthcare logo
Tenet HealthcareTHC
262.5M0.0%
Mannkind logo
MannkindMNKD
$3.1M+1.2%
United Therapeutics logo
United TherapeuticsUTHR
$800K0.0%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
200M0.0%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$1K0.0%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
500M+253,707%

Other financials

Income statement

See full
Revenue$132.9M+4,158%
Gross profit$1.6M+6.5%
Operating income$61.5M+274%
Net income$52.9M+238%
EPS (diluted)$0.52+216%

Balance sheet

See full
Cash & equivalents$222.8M+31.2%
Total debt$7.0M+1.5%
Total equity$108.6M+118%
Total assets$401.5M+76.6%

Cash flow

See full
Operating cash flow$53.0M+273%
CapEx$2.8M+758%
Free cash flow$50.2M+262%

Valuation

See full
Market cap$7.93B+356%
Enterprise value$7.71B+391%
P/S27.5×-62.3×

Profitability

See full
Gross margin58.1%-18.7pp
Operating margin-155%-68.1pp
Net margin-176.2%-76.4pp
FCF margin-150.7%-64.4pp

Returns & leverage

See full
Return on equity-181%+57.4pp
Debt / equity0.1×-0.1×
Current ratio2.2×-0.7×

Where this comes from

Reported directly by Liquidia Corporation in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The source filing: Liquidia Corporation’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 7:00 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-058252
Line itemMarch 31, 2026December 31, 2025
Commitments and contingencies (Note 13)
Stockholders’ equity:
Preferred stock — 10,000,000 shares authorized, none outstanding
Common stock — $0.001 par value, 115,000,000 shares authorized as of March 31, 2026 and December 31, 2025, respectively, 88,308,411 and 87,204,137 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively8887
Additional paid-in capital681,942670,974
Accumulated deficit(573,451)(626,313)
Total stockholders’ equity108,57944,748
Total liabilities and stockholders’ equity$401,533$327,934

Item 1. Condensed Financial Statements (unaudited)

FAQ

What is Liquidia Corporation's common stock?
Liquidia Corporation (LQDA) reported common stock of $88K in Q1 2026.
How has Liquidia Corporation's common stock changed year-over-year?
Liquidia Corporation's common stock increased by 3.5% year-over-year, from $85K to $88K.
What is the long-term trend for Liquidia Corporation's common stock?
Over 5 years (2020 to 2025), Liquidia Corporation's common stock has grown at a 15.0% compound annual growth rate (CAGR), from $43.34K to $87K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Ask your AI about Liquidia Corporation's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude